Literature DB >> 24566906

Tumour immunology: turning macrophages on, off and on again.

Gemma K Alderton1.   

Abstract

Mesh:

Year:  2014        PMID: 24566906     DOI: 10.1038/nri3634

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Sensitizing protective tumor microenvironments to antibody-mediated therapy.

Authors:  Christian P Pallasch; Ilya Leskov; Christian J Braun; Daniela Vorholt; Adam Drake; Yadira M Soto-Feliciano; Eric H Bent; Janine Schwamb; Bettina Iliopoulou; Nadine Kutsch; Nico van Rooijen; Lukas P Frenzel; Clemens M Wendtner; Lukas Heukamp; Karl Anton Kreuzer; Michael Hallek; Jianzhu Chen; Michael T Hemann
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

  1 in total
  7 in total

1.  The origin and function of tumor-associated macrophages.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

2.  The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production.

Authors:  Guiliang Xu; Guilin Liu; Sidong Xiong; Haiyan Liu; Xi Chen; Biao Zheng
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

Review 3.  Immunosuppressive cells in tumor immune escape and metastasis.

Authors:  Yang Liu; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2015-12-22       Impact factor: 4.599

Review 4.  Activation of phagocytosis by immune checkpoint blockade.

Authors:  Chia-Wei Li; Yun-Ju Lai; Jennifer L Hsu; Mien-Chie Hung
Journal:  Front Med       Date:  2018-07-30       Impact factor: 4.592

5.  Monocytes secrete CXCL7 to promote breast cancer progression.

Authors:  Yi-Hsiang Wang; Chia-Yi Shen; Sheng-Chieh Lin; Wen-Hung Kuo; Yuan-Ting Kuo; Yu-Ling Hsu; Wen-Ching Wang; Kai-Ti Lin; Lu-Hai Wang
Journal:  Cell Death Dis       Date:  2021-11-17       Impact factor: 8.469

6.  Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization.

Authors:  Lijuan Zhang; Kai Zhang; Jieyou Zhang; Jinrong Zhu; Qing Xi; Huafeng Wang; Zimu Zhang; Yingnan Cheng; Guangze Yang; Hongkun Liu; Xiangdong Guo; Dongmei Zhou; Zhenyi Xue; Yan Li; Qi Zhang; Yurong Da; Li Liu; Zhinan Yin; Zhi Yao; Rongxin Zhang
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 14.919

7.  Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).

Authors:  Yue Li; Hailin Liu; Yujie Zhao; Dongsheng Yue; Chen Chen; Chenguang Li; Zhenfa Zhang; Changli Wang
Journal:  Thorac Cancer       Date:  2021-08-22       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.